Developer of artificial intelligence-based diagnostic tests designed to support precision oncology and biomarker-driven medicine. Waiv is based in Paris, France. Its last reported valuation was $499 million in Mar 2026. It has raised $32.9 million.
Last reported valuation
$499.1M
Oct 2026
Priced at
—
Total raised
$32.9M
Last round
—
Cap table — not yet on record
Waiv's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Waiv with a free account
·Watch Waiv: the Monday email on marks, rounds and moves
